322 related articles for article (PubMed ID: 28857848)
21. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
[TBL] [Abstract][Full Text] [Related]
22. BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.
Niederman MS; Chastre J; Corkery K; Fink JB; Luyt CE; García MS
Intensive Care Med; 2012 Feb; 38(2):263-71. PubMed ID: 22147112
[TBL] [Abstract][Full Text] [Related]
23. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Colardyn F
J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
[TBL] [Abstract][Full Text] [Related]
24. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
[TBL] [Abstract][Full Text] [Related]
25. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.
Chastre J; Wolff M; Fagon JY; Chevret S; Thomas F; Wermert D; Clementi E; Gonzalez J; Jusserand D; Asfar P; Perrin D; Fieux F; Aubas S;
JAMA; 2003 Nov; 290(19):2588-98. PubMed ID: 14625336
[TBL] [Abstract][Full Text] [Related]
28. Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Palmer LB; Smaldone GC; Simon SR; O'Riordan TG; Cuccia A
Crit Care Med; 1998 Jan; 26(1):31-9. PubMed ID: 9428540
[TBL] [Abstract][Full Text] [Related]
29. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.
Heffernan AJ; Sime FB; Lipman J; Dhanani J; Andrews K; Ellwood D; Grimwood K; Roberts JA
Int J Antimicrob Agents; 2019 Mar; 53(3):234-245. PubMed ID: 30472292
[TBL] [Abstract][Full Text] [Related]
30. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
31. Aerosolized antibiotics to treat ventilator-associated pneumonia.
Luyt CE; Combes A; Nieszkowska A; Trouillet JL; Chastre J
Curr Opin Infect Dis; 2009 Apr; 22(2):154-8. PubMed ID: 19276883
[TBL] [Abstract][Full Text] [Related]
32. Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.
Pajot O; Burdet C; Couffignal C; Massias L; Armand-Lefevre L; Foucrier A; Da Silva D; Lasocki S; Laouénan C; Mentec H; Mentré F; Wolff M
J Antimicrob Chemother; 2015 May; 70(5):1487-94. PubMed ID: 25630642
[TBL] [Abstract][Full Text] [Related]
33. Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.
Bharathi KS; Bhat A; Pruthi G; Simha PP
Ann Card Anaesth; 2022; 25(4):435-440. PubMed ID: 36254907
[TBL] [Abstract][Full Text] [Related]
34. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.
Kollef MH; Ward S
Chest; 1998 Feb; 113(2):412-20. PubMed ID: 9498961
[TBL] [Abstract][Full Text] [Related]
35. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
36. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.
Montgomery AB; Vallance S; Abuan T; Tservistas M; Davies A
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):441-8. PubMed ID: 24383962
[TBL] [Abstract][Full Text] [Related]
37. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group.
Brun-Buisson C; Sollet JP; Schweich H; Brière S; Petit C
Clin Infect Dis; 1998 Feb; 26(2):346-54. PubMed ID: 9502454
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure.
Luyt CE; Eldon MA; Stass H; Gribben D; Corkery K; Chastre J
J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):183-90. PubMed ID: 21361783
[TBL] [Abstract][Full Text] [Related]
39. Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia.
Chastre J; Luyt CE
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S54-8. PubMed ID: 20597673
[TBL] [Abstract][Full Text] [Related]
40. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
Gu WJ; Wang F; Tang L; Bakker J; Liu JC
Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
